Immune Diseases Market for Drugs Treating Immune Diseases to Grow
The demand for symptom-treating drugs is expected to decline, but the market for immunomodulators is predicted to grow.
Wellesley/USA―According to BCC Research, the global market for drugs for the treatment of immune diseases was estimated to be approximately US$ 72.2 billion in 2010. It is forecast to grow to reach US$ 82.2 billion by 2015. Immunomodulators with an estimated markte size of US$ 62.8 billion in 2010 account for approximately 90 percent of the overall market. The demand for symptom–treating drugs is declining as advancements in immunology and life sciences help to target the underlying causes of the diseases. The market size is expected to decline at a compound annual growth rate of –3.1 percent.